ZUG, Switzerland, May 3, 2023 – MoonLake Immunotherapeutics (MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today ...

SHL Medical has secured financial support for the next phase of its drug delivery growth plan, bringing on board a consortium of investors that will enable it to add production capacity in the U.S.

SHL, the world's largest privately owned designer and manufacturer of advanced drug delivery devices, has just opened a new design and assembly center in the United States. Rapidly growing SHL is ...

TOKYO--(BUSINESS WIRE)--SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, announced today that SHL Marketing Director Steven Kaufman will ...

Swiss-based SHL Medical, a global developer and manufacturer of self-injection solutions has opened a $220m manufacturing facility in North Charleston, South Carolina, as part of its strategy to ...

Drug delivery specialist SHL Medical opened the doors to its new $220 million autoinjector production facility in South Carolina, further boosting the Swiss company’s global footprint. The facility, ...